<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(9)</volume><submitter>Wang W</submitter><pubmed_abstract>Oxidative damage and neuroinflammation are the key features of central nervous system (CNS) injury. Inspired by the neuroprotective properties of neural stem cell-derived exosomes (NExo) and the reactive oxygen species (ROS) scavenging ability of selenium, we develop an advanced NExo bearing ultrasmall nano-selenium (∼3.5 nm) via lipid-mediated nucleation (SeNExo). In addition to maintaining the biological components of NExo, the resulting SeNExo exhibits a Se-O bond that dramatically enhances its ROS-scavenging performance. SeNExo penetrates the blood-brain barrier (BBB) via the apolipoprotein E and prolow-density lipoprotein receptor-related protein 1 (APOE_LRP-1) interaction. Through proteomics, microRNA (miRNA) omics, and single-nucleus RNA sequencing, we find that SeNExo can alleviate</pubmed_abstract><journal>Cell reports. Medicine</journal><pagination>102319</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12490213</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Selenized neural stem cell-derived exosomes: A neotype therapeutic agent for traumatic injuries of the central nervous system.</pubmed_title><pmcid>PMC12490213</pmcid><pubmed_authors>Tan H</pubmed_authors><pubmed_authors>Qin M</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Wei W</pubmed_authors><pubmed_authors>Lyu C</pubmed_authors><pubmed_authors>Guo P</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Lu G</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors><pubmed_authors>Zheng D</pubmed_authors><pubmed_authors>Ma G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Selenized neural stem cell-derived exosomes: A neotype therapeutic agent for traumatic injuries of the central nervous system.</name><description>Oxidative damage and neuroinflammation are the key features of central nervous system (CNS) injury. Inspired by the neuroprotective properties of neural stem cell-derived exosomes (NExo) and the reactive oxygen species (ROS) scavenging ability of selenium, we develop an advanced NExo bearing ultrasmall nano-selenium (∼3.5 nm) via lipid-mediated nucleation (SeNExo). In addition to maintaining the biological components of NExo, the resulting SeNExo exhibits a Se-O bond that dramatically enhances its ROS-scavenging performance. SeNExo penetrates the blood-brain barrier (BBB) via the apolipoprotein E and prolow-density lipoprotein receptor-related protein 1 (APOE_LRP-1) interaction. Through proteomics, microRNA (miRNA) omics, and single-nucleus RNA sequencing, we find that SeNExo can alleviate</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-04T01:51:13.592Z</modification><creation>2026-05-04T03:14:09.966Z</creation></dates><accession>S-EPMC12490213</accession><cross_references><pubmed>40882623</pubmed><doi>10.1016/j.xcrm.2025.102319</doi></cross_references></HashMap>